CNST - Constellation Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

Constellation Pharmaceuticals's activity chart (see below) currently has 43 price targets and 32 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 48.74% of the time, taking 161.44 days on average.

Most recent stock forecast was given by BRIAN ABRAHAMS from RBC on 17-Jun-2021. First documented stock forecast 13-Aug-2018.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 04-Sep-2019

$34

$50

5 years 5 months 5 days ago
(17-Jun-2021)

3/7 (42.86%)

$0.18 (0.53%)

37

Buy Since 05-Jun-2020

$34

$50

5 years 5 months 19 days ago
(03-Jun-2021)

0/2 (0%)

$0.16 (0.47%)

Buy Since 10-May-2021

$34

$48

5 years 5 months 20 days ago
(02-Jun-2021)

5/8 (62.5%)

$0.43 (1.28%)

197

Buy Since 13-Aug-2018

$34

5 years 5 months 20 days ago
(02-Jun-2021)

1/2 (50%)

$0.43 (1.28%)

450

Hold Since 08-Sep-2020

$20

$47

6 years 2 months 14 days ago
(08-Sep-2020)

2/4 (50%)

$-0.27 (-1.33%)

14

Show more analysts

Please expand the browser size to see the chart

What is CNST (Constellation Pharmaceuticals) average time for price targets to be met?

On average it took 161 days for the stock forecasts to be reached, with an average price target met ratio of 48.74%.

Which analyst most recently updated their price target on CNST (Constellation Pharmaceuticals)?

Brian Abrahams

Which analyst has the lowest performance score on CNST (Constellation Pharmaceuticals) with a proven track record?

ANDREW FEIN

Which analyst has the most public recommendations on CNST (Constellation Pharmaceuticals)?

Brian Abrahams works at RBC and has 42 price targets and 25 ratings on CNST

Which analyst is the currently most bullish on CNST (Constellation Pharmaceuticals)?

Andrew Fein with the highest potential upside of $41.01

Which analyst is the currently most reserved on CNST (Constellation Pharmaceuticals)?

Silvan Tuerkcan with the lowest potential downside of -$13.99
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?